This document is a publication of a European patent application (EP4059946A1) by Nibec Co., Ltd. for a peptide designed to treat inflammation and wounds. The publication includes the inventors' names and various International Patent Classification (IPC) codes related to the peptide's composition and therapeutic applications, such as C07K 7/08, A61P 17/02, A61P 29/00, A61P 37/00, and A61K 38/00.

This patent publication does not impose any new regulatory obligations or compliance deadlines on regulated entities. It serves as a notice of intellectual property protection for the applicant's invention. Compliance officers in the pharmaceutical and medical device sectors should note this publication as part of their competitive intelligence and intellectual property landscape monitoring.